Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Neoplasia (New York, N.Y.)
|
October 27, 2011
Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells
Philip A Knobel, Ilya N Kotov, Emanuela Felley-Bosco, et al.
Cancers
|
November 10, 2020
Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer
Haitang Yang, Liang Zhao, Yanyun Gao, et al.
Molecular Cancer
|
October 24, 2007
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Larisa L Belyanskaya, Thomas M Marti, Sally Hopkins-Donaldson, et al.
Respiratory Research
|
November 29, 2025
Variable steady inflammation and inflammatory responses in precision-cut lung slices from various IPF lung Regions
Carlos Machahua, Thomas M Marti, Namrata Kewalramani, et al.
Virchows Archiv : an International Journal of Pathology
|
January 8, 2017
Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer
Sabina Berezowska, José A Galván, Rupert Langer, et al.
Cancers
|
October 27, 2022
Dissecting the Immunological Profiles in <i>NSD3</i>-Amplified LUSC through Integrative Multi-Scale Analyses
Duo Xu, Shengchen Liu, Xi Wu, et al.
Lab on a Chip
|
February 6, 2014
A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids
Janine Ruppen, Lourdes Cortes-Dericks, Emanuele Marconi, et al.
Angiogenesis
|
July 4, 2018
Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro
Soheila Zeinali, Colette A Bichsel, Nina Hobi, et al.
Cancer Cell International
|
December 5, 2019
Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
Yanyun Gao, Patrick Dorn, Shengchen Liu, et al.
Frontiers in Bioengineering and Biotechnology
|
October 23, 2024
Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model
Karin F Schmid, Soheila Zeinali, Susanne K Moser, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Neoplasia (New York, N.Y.)
|
October 27, 2011
Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells
Philip A Knobel, Ilya N Kotov, Emanuela Felley-Bosco, et al.
Cancers
|
November 10, 2020
Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer
Haitang Yang, Liang Zhao, Yanyun Gao, et al.
Molecular Cancer
|
October 24, 2007
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Larisa L Belyanskaya, Thomas M Marti, Sally Hopkins-Donaldson, et al.
Respiratory Research
|
November 29, 2025
Variable steady inflammation and inflammatory responses in precision-cut lung slices from various IPF lung Regions
Carlos Machahua, Thomas M Marti, Namrata Kewalramani, et al.
Virchows Archiv : an International Journal of Pathology
|
January 8, 2017
Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer
Sabina Berezowska, José A Galván, Rupert Langer, et al.
Cancers
|
October 27, 2022
Dissecting the Immunological Profiles in <i>NSD3</i>-Amplified LUSC through Integrative Multi-Scale Analyses
Duo Xu, Shengchen Liu, Xi Wu, et al.
Lab on a Chip
|
February 6, 2014
A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids
Janine Ruppen, Lourdes Cortes-Dericks, Emanuele Marconi, et al.
Angiogenesis
|
July 4, 2018
Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro
Soheila Zeinali, Colette A Bichsel, Nina Hobi, et al.
Cancer Cell International
|
December 5, 2019
Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
Yanyun Gao, Patrick Dorn, Shengchen Liu, et al.
Frontiers in Bioengineering and Biotechnology
|
October 23, 2024
Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model
Karin F Schmid, Soheila Zeinali, Susanne K Moser, et al.
Page
of 6